Our aim was to assess the capability of this novel approach to identify numerical abnormalities of chromosomes 4 and 21, the initiating ETV6::RUNX1 translocation, as well as secondary gains and losses of ETV6 and RUNX1 in paediatric B-ALL at diagnosis. This evidence concerns the gene RUNX1 and precursor B-cell acute lymphoblastic leukemia.